Home » Newsletters » BioWorld Science

BioWorld Science

April 6, 2020

View Archived Issues

A20's inflammation-fighting properties decoded

Discovery and preclinical evaluation of an oral nicotinic acetylcholine alpha7 receptor PAM

Discovery of ketone-linked benzimidazole-benzoxaborole hybrids for the treatment of onchocerciasis

JAM2 is recurrently mutated in families with recessive primary familial brain calcification

Capricor initiates compassionate use program for patients with severe COVID-19

Futura Medical presents further detailed data from FM57 phase III study of MED-3000

Horizon Therapeutics acquires LPA1 receptor antagonist for dcSSc

Positive interim data from phase IIb study of UGN-102

Mouse model of COPD established through use of intratracheal spray

Novel diet-induced obese rat model of AF

Optogenetic plaque model traces neurodegeneration in AD

Microbiome changes precede tumor development in CRC

Collaboration between UW-Madison, FluGen and Bharat Biotech to develop COVID-19 vaccine

Ivermectin, approved as an antiparasitic, inhibits SARS-CoV-2 in vitro

Inositec patents calcium oxalate crystallization inhibitors

Aprea Therapeutics divulges quinuclidine derivatives for cancer

Chinese investigators identify new TLR8 agonists

ViiV Healthcare presents compounds for HIV infection

New HER2 inhibitors identified by Suzhou Zanrong Pharma

SHR-1701 begins new phase I trials for advanced solid tumors and nasopharyngeal carcinoma

European Commission approves Rybelsus for type 2 diabetes

Union Therapeutics announces program with optimized salt form of niclosamide to treat COVID-19

FDA approves Reblozyl to treat anemia in MDS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 3, 2025.
Researchers arm CAR T cells to fight solid tumors
BioWorld
Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the...
Bioversys, Shionogi in CHF529M lung infection collaboration
BioWorld Science
Antibiotics specialist Bioversys AG has sealed a potential CHF529 million (US$667.5 million) deal with Shionogi Co. Ltd., in which they will work together on...
Medtronic receives CE mark for its Vitalflow ECMO system
BioWorld MedTech
Medtronic plc received a CE mark for its Vitalflow extracorporeal membrane oxygenation (ECMO) system, which provides temporary support for the heart and lungs in...